Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDP

Project: Clinical Trial

Project Details

StatusActive
Effective start/end date4/15/20 → …